Asthmatics face a deadline of December 31, 2011 to switch from using epinephrine inhalers to other prescription treatment methods under an order from the Food and Drug Administration. At issue is the ...
Please provide your email address to receive an email when new articles are posted on . Epinephrine autoinjector costs will be capped at $25 and asthma inhaler costs will be capped at $50. These ...
TRENTON, N.J. (AP) — A new version of the once-popular asthma inhaler Primatene Mist will soon return to U.S. stores. The Food and Drug Administration approved the over-the-counter aerosol inhaler ...
WASHINGTON – Asthma sufferers may not be able to buy nonprescription inhalers much longer because the devices contain propellants that harm the ozone layer. An advisory panel voted 11-7 Tuesday to ...
The recent FDA decision to put the metered-dose epinephrine inhaler Primatene Mist™ back on drugstore shelves was met with alarm by asthma specialists and respiratory health groups who warned that the ...
WASHINGTON -- Asthma patients who rely on over-the-counter inhalers will need to switch to prescription-only alternatives as part of the federal government's latest attempt to protect the Earth's ...
Asthma sufferers may not be able to buy nonprescription inhalers much longer because the devices contain propellants that harm the ozone layer. An advisory panel voted 11-7 Tuesday to recommend that ...
This undated product image provided by Amphastar shows Primatene Mist. A new version of the once-popular asthma inhaler Primatene Mist will soon return to U.S. stores. The Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results